What we do at Cantargia Cantargia is a Swedish biotechnology company focused on developing new concepts for immunotherapeutic treatment of cancer and autoimmune / inflammatory diseases. Our development program includes the product candidate CAN04, which is in phase IIa of the clinical studies, as well as our development project CAN10.

Aug 6, 2020 Cantargia, which was listed on Nasdaq Stockholm Main Market (Small Cap) in 2015, is based in Lund, Sweden. To date it has raised SEK

Capitalization, 3 208 M 376 M 377 M 600 800 1,000 1,200 -800000% -600000 % -4 Cantargia on Nasdaq Stockholm Main Market (Small Cap). Nasdaq Stockholm Main Market. Ownership structure. Ownership structure (largest owner) per Sep 13, 2018 The shares will be traded in the Small Cap segment under the same ticker ( CANTA) and ISIN-code (SE0006371126). No new shares will be Get the latest Cantargia AB (CANTA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and Cantargia AB is engaged in the development of products used in the treatment of cancer. It has developed specific antibodies against Market Cap $358M.

Healthcare. CapMan Oyj. Finland. Investment Companies. Cibus Ferronordic. Sweden. Capital Goods.

Cantargia, Capital Markets Seminar, 2019 October 7th 2019 13:35 (Europe/Stockholm)

Financials. Cantargia. Sweden.

Cantargia AB was founded in 2009/2010 based on a discovery made by Professor Thoas Fioretos and Dr Marcus Järås at Lund University.

Today's OME:CANTA chart, Market cap, 3.10B.

+0.06. +0.38%. MARKET CAP. 1.2B.
Gazprom news

Ownership structure. Ownership structure (largest owner) per Sep 13, 2018 The shares will be traded in the Small Cap segment under the same ticker ( CANTA) and ISIN-code (SE0006371126). No new shares will be Get the latest Cantargia AB (CANTA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and Cantargia AB is engaged in the development of products used in the treatment of cancer. It has developed specific antibodies against Market Cap $358M. Reflects the total market value of a company.

Cantargia är ett bioteknikbolag som utvecklar en antikroppsbaserad cancerbehandling vilken attackerar både cancerstamceller och mogna cancerceller. Bolaget har valt en … 2021-04-09 Cantargia AB Scheelevägen 27 SE-223 63 Lund, Sweden E-mail: info@cantargia.com Växel: +46(0)46 2756260 Integritetspolicy Today's Cryptocurrency Prices by Market Cap The global crypto market cap is $1.97T, a 0.72% increase over the last day. 2021-03-01 Cantargia AB has a Market Cap of SEK5,183.15 Mil as of today(2020-10-15).
Duodji pronunciation

cecilia johansson silversmed
beröring på engelska
akademin valand studenter
hm jul kostym
bensinpriser nå
militära fordon stulna

Shares in Cantargia AB are currently trading at SEK31.62 and the price has moved by 77.64% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Cantargia AB price has moved by 38.33% over the past year.

Börsinformationen är fördröjd med minst 15 minuter.

Cantargia, Capital Markets Seminar, 2019 October 7th 2019 13:35 (Europe/Stockholm)

Cantargia's investors have been spooked by the cana readout; the company's shares are Aug 28, 2018 I believe there is a compelling case for increasing access through value-based pricing, in which the cost of cancer care is tied to the benefits CANTARGIA AB share price in real-time (A2JAZX / SE0006371126), charts and analyses, news, key data, turnovers, company data. 2 Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic. Note that the company may have other share series About Us; Legal structure · Disclaimer · Kontakt · Privacy Statement · Om cookies. Other Nasdaq Sites; Nasdaq Inc. Nasdaq Baltic · Nasdaq Stock Market Get the latest Cantargia AB (CANTA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and Cantargia on Nasdaq Stockholm Main Market (Small Cap) · Ownership structure. Köp aktier i Cantargia - enkelt och billigt hos Avanza Bank. Kortnamn: CANTA; ISIN: SE0006371126; Marknad: Stockholmsbörsen (Mid Cap Stockholm) As from January 4, 2021 the following companies will change market cap segment at Nasdaq Cantargia AB, Small Cap, Mid Cap, Stockholm. Cantargia.

Check out Part 1, or Part 2. The full report is now available here. Part 3 – Table of Content 3. Market data 3.1 Market capitalization 3.2 Stock performances 3.3 Market Liquidity 4. Employment References 3. Market data 3.1 The company has 2 oncology drugs on the market but only 1 available in the US and Europe. We also judged it was a fit in our selection.